WednesdayDec 17, 2025 12:25 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the brain and central nervous system, reported a leadership transition under which John Climaco has stepped down as chief executive officer and Rami Levin, MBA, has been appointed president and chief executive officer, effective Jan. 1, 2026. Levin brings nearly three decades of global leadership experience across oncology, neurology and rare diseases, with a track record of advancing late-stage clinical programs, scaling organizations and leading strategic turnarounds, positioning CNS to advance its pipeline and next phase of development. To view the full press release, visit https://ibn.fm/FBByV About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a…

Continue Reading

MondayDec 15, 2025 9:10 am

TinyGemsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Taps Hockey Hall of Famer Jeremy Roenick to Advise International NIL Exchange Initiative

Datavault AI (NASDAQ: DVLT), a provider of patented agentic AI platforms for data observation, valuation and monetization, today announced that Hockey Hall of Famer Jeremy Roenick is advising the Company on the development of its Sports and Entertainment initiative through the forthcoming International NIL Exchange, building on recent partnerships including the World Boxing Council and Dream Bowl. Roenick will support expansion of the platform, which is powered by Datavault AI patented Data Vault, DataScore(R) and DataValue(R) AI agents and enables indexing and tokenization of sports and entertainment assets for trading on the patented Information Data Exchange(R) via the New York…

Continue Reading

WednesdayDec 10, 2025 2:50 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Qubits 2026 Quantum Computing User Conference

D-Wave Quantum Inc. (NYSE: QBTS), (“D-Wave”) a leader in quantum computing systems, software and services, announced its annual Qubits user conference will take place January 27 and 28, 2026, in Boca Raton, Florida. Featuring talks from D-Wave’s executives, customers, industry leaders, and scientists, the event will highlight how the company’s energy-efficient annealing quantum computers and hybrid-quantum solvers are delivering measurable impact today. In addition, D-Wave will share its latest technology roadmap for both annealing and gate-model initiatives, underscoring its leadership in delivering commercial-grade superconducting quantum technology and outlining its strategic vision for the future. One of the premier quantum computing…

Continue Reading

MondayDec 01, 2025 11:10 am

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Announces Leadership Changes as Board Appoints Robert Stubblefield Interim CEO

SEGG Media (NASDAQ: SEGG, LTRYW) said its Board terminated CEO, Secretary and President Matthew McGahan and removed him as Chairman, appointing CFO Robert Stubblefield as Interim CEO, Secretary and President and naming Marc Bircham Chairman. McGahan will remain a Director until his term expires at the upcoming annual meeting. The Company said the leadership transition supports its next phase of growth as it scales Sports.com, Concerts.com and Lottery.com, with more than 102 million views across platforms in 2025, and prepares for planned acquisitions. Stubblefield said the focus is on financial stability, disciplined execution and rebuilding shareholder value, while guiding expansion…

Continue Reading

MondayNov 17, 2025 11:01 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study 

CNS Pharmaceuticals (NASDAQ: CNSP) reported third-quarter 2025 results and highlighted continued progress with TPI 287, its blood-brain barrier–permeable abeotaxane in development for glioblastoma and other CNS tumors. The Company noted Phase 1 data showing potential BBB penetration and tumor responses, including 3 complete and 9 partial responses among 23 evaluable patients treated with TPI 287 plus bevacizumab, and plans to engage the FDA early next year on a registration-focused Phase 2 trial design in recurrent GBM. For the quarter, CNS reported a net loss of $3.3 million, R&D expenses of $2.2 million and G&A expenses of $1.1 million, ending the…

Continue Reading

ThursdayNov 13, 2025 1:35 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Signs LOI to Acquire Triggy.AI to Advance AI-Driven Engagement and Monetization 

SEGG Media (NASDAQ: SEGG, LTRYW) signed a binding Letter of Intent to acquire Triggy.AI, an AI technology company specializing in dynamic ad-revenue formats and gamified engagement solutions, with closing expected on or before Nov. 28. Founded by gaming and sports-technology entrepreneurs, Triggy provides an AI engine used by international brands to deliver personalized, real-time interactions that boost engagement, dwell time and conversions, supporting predictable recurring revenue from enterprise clients. SEGG Media plans to integrate Triggy’s technology across Sports.com, Lottery.com and Concerts.com to expand next-generation content experiences and data-driven monetization, a move praised by executives from both companies as a major…

Continue Reading

ThursdayNov 06, 2025 9:00 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and BASF Complete Proof-of-Concept Project, Demonstrating Benchmark in Manufacturing Efficiency

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services, and BASF, one of the world’s leading chemical companies, have completed a joint proof-of-concept project that used a hybrid-quantum application to optimize manufacturing workflows in a BASF liquid-filling facility. D-Wave's hybrid-quantum technology set a new benchmark for manufacturing efficiency, allowing reduction of production scheduling time from 10 hours to just seconds, reducing lateness by 14% and setup times by 9%, and shortening tank unloading durations by up to 18%. “This project showcases how hybrid-quantum computing can help address manufacturing and supply-chain operational bottlenecks and begin delivering measurable value…

Continue Reading

WednesdayNov 05, 2025 11:30 am

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL, NXPLW) Subsidiary PharmcoRx Awarded Multi-State Prescription Fulfillment Contract From DevotedDOc 

NextPlat (NASDAQ: NXPL, NXPLW), a global provider of healthcare and technology solutions through e-commerce and retail channels, announced that its PharmcoRx subsidiary has secured an exclusive multi-state prescription fulfillment services contract from DevotedDOc, a virtual medical group specializing in urgent care, Medication-Assisted Treatment for opioid use disorder, and compounded alternatives to GLP-1 therapies for weight loss and hormone replacement therapy. PharmcoRx will begin serving patients in Florida and Georgia in November, with plans to expand nationally across its licensed territories. Vice President of Healthcare Operations Birute Norkute said the partnership underscores NextPlat’s commitment to improving access to rapid, affordable, and…

Continue Reading

MondayNov 03, 2025 2:01 pm

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL, NXPLW) to Announce Q3 2025 Financial Results on Nov. 13 

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, will release its financial results for the quarter ended Sept. 30, 2025, before market open on Nov. 13, 2025. CEO and President of Global Operations David Phipps, CFO Amanda Ferrio, and Vice President of Healthcare Operations Birute Norkute will host a conference call that day at 8:30 a.m. ET to discuss the results and other recent developments. To view the full press release, visit: https://ibn.fm/CKEc6 About NextPlat Corp. Nextplat is a global consumer products and services company providing healthcare…

Continue Reading

ThursdayOct 30, 2025 9:00 am

TinyGemsBreaks – D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the third quarter of fiscal year 2025 ended September 30, 2025 on Thursday, November 6 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavesys.com/. In conjunction with this announcement, D-Wave will host a conference call on Thursday, November 6, 2025, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-844-826-3035 (domestic) or 1-412-317-5195 (international). Participants can use those dial-in numbers or can click this link for instant…

Continue Reading

Contact us: (512) 354-7000